Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan
Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan
The Preempt study is likely to help determine the frequency of patients suffering from
 Minimal Hepatic Encephalopathy (MHE) and are cirrhotics. It will also enable us to know about
 the Quality of life of these patients.
Inclusion Criteria:

 -  Patients of either sex, 18-65 years of age, who have attended school at least till the
 5th Class/Standard having an established diagnosis of liver cirrhosis without any
 overt symptoms at time of testing with Grade 0 of West Haven criteria.

 -  Patients willing to undergo the neuropsychological (NP) tests and to complete the
 SF-36 questionnaire for the estimation of Health Related Quality of Life (HRQOL).

 -  Patients willing to provide written authorization to provide data for the study.

 Exclusion Criteria:

 -  Patients with inability to perform neuropsychometric tests and to complete the SF-36
 questionnaire as decided by the physician.